{"id":23789,"date":"2018-03-02T18:29:34","date_gmt":"2018-03-02T18:29:34","guid":{"rendered":"https:\/\/backspace.agency\/innventa\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/"},"modified":"2024-08-02T22:57:40","modified_gmt":"2024-08-02T22:57:40","slug":"exponential-growth-innventa-in-healthcarelifescience-review-serbia","status":"publish","type":"post","link":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/","title":{"rendered":"Exponential growth-Innventa in HealthCare&#038;Lifescience Review Serbia"},"content":{"rendered":"<p>In interview for the prestigious international publication, general director of INNventa-pharm, Goran Orlic, discusses the rationale behind establishing his own company that continues to double revenues year on year. He highlighted the company\u2019s fundamental role in providing innovative<br \/>\nsolutions to Serbian patients, pharmacists and doctors.<\/p>\n<p>Pharmaboardroom is the official Internet platform of HealthCare &amp; Lifescience Review, with leading companies, consultants, institutions and pharma experts from the pharmaceutical sector of respective markets.<\/p>\n<p>Complete Serbia market review can be downloaded on below link, where more details about Innventa pharm can be found on pages 19,35 and 36:<\/p>\n<p><a href=\"Complete Serbia market review can be downloaded on below link, where more details about Innventa pharm can be found on pages 19,35 and 36: https:\/\/pharmaboardroom.com\/country_reports\/serbia-pharma-report\/\">https:\/\/pharmaboardroom.com\/country_reports\/serbia-pharma-report\/<\/a><\/p>\n<p><a href=\"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/Pharmaboardroom-page-019.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-4059\" src=\"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/Pharmaboardroom-page-019-221x300.jpg\" alt=\"\" width=\"348\" height=\"473\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In interview for the prestigious international publication, general director of INNventa-pharm, Goran Orlic, discusses the rationale behind establishing his own company that continues to double revenues year on year. He highlighted the company\u2019s fundamental role in providing innovative solutions to Serbian patients, pharmacists and doctors. Pharmaboardroom is the official Internet platform of HealthCare &amp; Lifescience [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":23786,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[269,270,271,272],"class_list":["post-23789","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-heathcarelifescience-review-serbia-2018-en","tag-innventa-exponential-growth-en","tag-innventa-pharmaboardroom-2018-en","tag-pharmaboardroom-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exponential growth-Innventa in HealthCare&amp;Lifescience Review Serbia - INNventa Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exponential growth-Innventa in HealthCare&amp;Lifescience Review Serbia - INNventa Pharm\" \/>\n<meta property=\"og:description\" content=\"In interview for the prestigious international publication, general director of INNventa-pharm, Goran Orlic, discusses the rationale behind establishing his own company that continues to double revenues year on year. He highlighted the company\u2019s fundamental role in providing innovative solutions to Serbian patients, pharmacists and doctors. Pharmaboardroom is the official Internet platform of HealthCare &amp; Lifescience [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/\" \/>\n<meta property=\"og:site_name\" content=\"INNventa Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/INNventaPharm\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-02T18:29:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-02T22:57:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/pharma-boardroom-feat.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"INNventa Pharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"INNventa Pharm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/\"},\"author\":{\"name\":\"INNventa Pharm\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#\\\/schema\\\/person\\\/889b3a72be927cdef8161a4a4995d3b1\"},\"headline\":\"Exponential growth-Innventa in HealthCare&#038;Lifescience Review Serbia\",\"datePublished\":\"2018-03-02T18:29:34+00:00\",\"dateModified\":\"2024-08-02T22:57:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/\"},\"wordCount\":107,\"publisher\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innventa-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/pharma-boardroom-feat.jpg\",\"keywords\":[\"heathcare&amp;lifescience review serbia 2018\",\"innventa exponential growth\",\"innventa pharmaboardroom 2018\",\"pharmaboardroom\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/\",\"url\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/\",\"name\":\"Exponential growth-Innventa in HealthCare&Lifescience Review Serbia - INNventa Pharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innventa-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/pharma-boardroom-feat.jpg\",\"datePublished\":\"2018-03-02T18:29:34+00:00\",\"dateModified\":\"2024-08-02T22:57:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innventa-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/pharma-boardroom-feat.jpg\",\"contentUrl\":\"https:\\\/\\\/innventa-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/pharma-boardroom-feat.jpg\",\"width\":1200,\"height\":650},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/news\\\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exponential growth-Innventa in HealthCare&#038;Lifescience Review Serbia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/\",\"name\":\"INNventa Pharm\",\"description\":\"Innovative Pharma Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#organization\",\"name\":\"INNventa Pharm\",\"url\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/innventa-pharm.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/innventa-favicon-2017.png\",\"contentUrl\":\"https:\\\/\\\/innventa-pharm.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/innventa-favicon-2017.png\",\"width\":512,\"height\":512,\"caption\":\"INNventa Pharm\"},\"image\":{\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/INNventaPharm\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/innventa-pharm.com\\\/en\\\/#\\\/schema\\\/person\\\/889b3a72be927cdef8161a4a4995d3b1\",\"name\":\"INNventa Pharm\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exponential growth-Innventa in HealthCare&Lifescience Review Serbia - INNventa Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/","og_locale":"en_US","og_type":"article","og_title":"Exponential growth-Innventa in HealthCare&Lifescience Review Serbia - INNventa Pharm","og_description":"In interview for the prestigious international publication, general director of INNventa-pharm, Goran Orlic, discusses the rationale behind establishing his own company that continues to double revenues year on year. He highlighted the company\u2019s fundamental role in providing innovative solutions to Serbian patients, pharmacists and doctors. Pharmaboardroom is the official Internet platform of HealthCare &amp; Lifescience [&hellip;]","og_url":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/","og_site_name":"INNventa Pharm","article_publisher":"https:\/\/www.facebook.com\/INNventaPharm","article_published_time":"2018-03-02T18:29:34+00:00","article_modified_time":"2024-08-02T22:57:40+00:00","og_image":[{"width":1200,"height":650,"url":"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/pharma-boardroom-feat.jpg","type":"image\/jpeg"}],"author":"INNventa Pharm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"INNventa Pharm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/#article","isPartOf":{"@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/"},"author":{"name":"INNventa Pharm","@id":"https:\/\/innventa-pharm.com\/en\/#\/schema\/person\/889b3a72be927cdef8161a4a4995d3b1"},"headline":"Exponential growth-Innventa in HealthCare&#038;Lifescience Review Serbia","datePublished":"2018-03-02T18:29:34+00:00","dateModified":"2024-08-02T22:57:40+00:00","mainEntityOfPage":{"@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/"},"wordCount":107,"publisher":{"@id":"https:\/\/innventa-pharm.com\/en\/#organization"},"image":{"@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/#primaryimage"},"thumbnailUrl":"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/pharma-boardroom-feat.jpg","keywords":["heathcare&amp;lifescience review serbia 2018","innventa exponential growth","innventa pharmaboardroom 2018","pharmaboardroom"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/","url":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/","name":"Exponential growth-Innventa in HealthCare&Lifescience Review Serbia - INNventa Pharm","isPartOf":{"@id":"https:\/\/innventa-pharm.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/#primaryimage"},"image":{"@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/#primaryimage"},"thumbnailUrl":"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/pharma-boardroom-feat.jpg","datePublished":"2018-03-02T18:29:34+00:00","dateModified":"2024-08-02T22:57:40+00:00","breadcrumb":{"@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/#primaryimage","url":"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/pharma-boardroom-feat.jpg","contentUrl":"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2024\/07\/pharma-boardroom-feat.jpg","width":1200,"height":650},{"@type":"BreadcrumbList","@id":"https:\/\/innventa-pharm.com\/en\/news\/exponential-growth-innventa-in-healthcarelifescience-review-serbia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innventa-pharm.com\/en\/"},{"@type":"ListItem","position":2,"name":"Exponential growth-Innventa in HealthCare&#038;Lifescience Review Serbia"}]},{"@type":"WebSite","@id":"https:\/\/innventa-pharm.com\/en\/#website","url":"https:\/\/innventa-pharm.com\/en\/","name":"INNventa Pharm","description":"Innovative Pharma Solutions","publisher":{"@id":"https:\/\/innventa-pharm.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innventa-pharm.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/innventa-pharm.com\/en\/#organization","name":"INNventa Pharm","url":"https:\/\/innventa-pharm.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/innventa-pharm.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2023\/03\/innventa-favicon-2017.png","contentUrl":"https:\/\/innventa-pharm.com\/wp-content\/uploads\/2023\/03\/innventa-favicon-2017.png","width":512,"height":512,"caption":"INNventa Pharm"},"image":{"@id":"https:\/\/innventa-pharm.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/INNventaPharm"]},{"@type":"Person","@id":"https:\/\/innventa-pharm.com\/en\/#\/schema\/person\/889b3a72be927cdef8161a4a4995d3b1","name":"INNventa Pharm"}]}},"_links":{"self":[{"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/posts\/23789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/comments?post=23789"}],"version-history":[{"count":3,"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/posts\/23789\/revisions"}],"predecessor-version":[{"id":24769,"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/posts\/23789\/revisions\/24769"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/media\/23786"}],"wp:attachment":[{"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/media?parent=23789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/categories?post=23789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/innventa-pharm.com\/en\/wp-json\/wp\/v2\/tags?post=23789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}